Some important factors to consider include allergic responses, injection site reactions, electrolyte imbalances, kidney and liver function, skin-lightening concerns, drug interactions, gastrointestinal disturbances, and long-term safety
Quick Answer: GLP-1 receptor agonists do not directly cause vision problems, but may worsen diabetic retinopathy in patients with pre-existing eye disease who experience rapid blood glucose improvements
Semaglutide, by contrast, is approved for chronic long-term use
Get crisis therapeutic offer assistance if you have signs of an unfavorably susceptible response: hives, tingling, discombobulation, quick heartbeats, trouble breathing, swelling of your confront, lips, tongue, or throat.
The FDA has said theres no legal basis for selling BPC-157 as a drug, supplement or compounded medication, and enforcement letters have specifically called out the research-use disclaimer as a loophole that doesnt hold up once a product is bundled with injection supplies or marketed with human-use instructions